Karuna Therapeutics Inc


Market Cap$12.05B

Compare Karuna Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Karuna Therapeutics IncKaruna Therapeutics Inc-30.40%-30%--
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Target Price by Analysts

4.4% upsideKaruna Therapeutics Target Price DetailsTarget Price

Current Fair Value

3.8% upside

Undervalued by 3.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.05 Billion
Enterprise Value$10.72 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-10.97
Outstanding Shares37,727,117
Avg 30 Day Volume616,725


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-30.42
Price to Sales-
Price to Book Ratio9.03
Enterprise Value to Revenue1807.72
Enterprise Value to EBIT-23.82
Enterprise Value to Net Income-28
Total Debt to Enterprise0
Debt to Equity0.01

Revenue Sources

No data

ESG Score

No data

About Karuna Therapeutics Inc